Article Text

Download PDFPDF
Paper
Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?
  1. Scott Y H Kim1,2,
  2. Raymond De Vries2,3,
  3. Sonali Parnami2,
  4. Renee Wilson4,
  5. H Myra Kim5,
  6. Samuel Frank6,
  7. Robert G Holloway7,8,
  8. Karl Kieburtz4,7,9
  1. 1Department of Bioethics, National Institutes of Health, Bethesda, Maryland, USA
  2. 2Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, Michigan, USA
  3. 3Department of Medical Education, University of Michigan, Ann Arbor, Michigan, USA
  4. 4Center for Human Experimental Therapeutics, University of Rochester, Rochester, New York, USA
  5. 5Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA
  6. 6Department of Neurology, Boston University, Boston, Massachusetts, USA
  7. 7Department of Neurology, University of Rochester, Rochester, New York, USA
  8. 8Department of Community and Preventive Medicine, University of Rochester, Rochester, New York, USA
  9. 9Department of Environmental Medicine, University of Rochester, Rochester, New York, USA
  1. Correspondence to Dr Scott Kim, Department of Bioethics, National Institutes of Health, 10 Center Drive, 1C118, Bethesda, MD 20892-1156, USA; scott.kim{at}nih.gov

Abstract

Background Desire for improvement in one's illness and having one's own doctor functioning as a researcher are thought to promote therapeutic misconception (TM), a phenomenon in which research subjects are said to conflate research with treatment.

Purpose To examine whether subjects’ therapeutic motivation and own doctor functioning as researcher are associated with TM.

Methods We interviewed 90 persons with advanced Parkinson's disease (PD) enrolled or intending to enrol in sham surgery controlled neurosurgical trials, using qualitative interviews. Subjects were compared by motivation (primarily therapeutic vs primarily altruistic or dually motivated by altruistic and therapeutic motivation), and by doctor status (own doctor as site investigator vs not) on the following: understanding of purpose of study; understanding of research procedures; perception of chance of direct benefit; and recollection and perceptions concerning the risks.

Results 60% had primarily therapeutic motivation and 44% had their own doctor as the site investigator, but neither were generally associated with increased TM responses. Overall level of understanding of purpose and procedures of research were high. Subjects responded with generally high estimates of probability of direct benefit, but their rationales were personal and complex. The therapeutic-motivation group was more sensitive to risks. Five (5.6%) subjects provided incorrect answers to the question about purpose of research, and yet, showed excellent understanding of research procedures.

Conclusions In persons with PD involved in sham surgery clinical trials, being primarily motivated by desire for direct benefit to one's illness or having one's own doctor as the site investigator were not associated with greater TM responses.

  • Research Ethics
  • Gene Therapy/Transfer
  • Clinical trials
  • Decision-making
  • Policy Guidelines/Inst. Review Boards/Review Cttes.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.